Literature DB >> 6824820

Selective inhibition of thromboxane B2 accumulation and metabolism in perfused guinea-pig lung.

J R Hoult, C Robinson.   

Abstract

1 U46619, a prostaglandin H2 endoperoxide analogue and thromboxane A2 agonist, dose-dependently inhibited accumulation and metabolism of thromboxane B2 in the isolated perfused lung of the guinea-pig. At similar doses prostaglandins E1, E2, F1 alpha, F2 alpha, I2, 5, 6-trans-PGE2 and 8-iso-PGE1 were ineffective. 2 U46619 did not affect accumulation and metabolism of prostaglandin F2 alpha under similar conditions. 3 The pulmonary disposition of thromboxane B2, which occurs by uptake into pulmonary cells or binding to a specific macromolecular component, is mediated by a mechanism distinct from that handling prostaglandin F2 alpha. The possible relevance of these findings to the pulmonary disposition of thromboxane A2 is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6824820      PMCID: PMC2044786          DOI: 10.1111/j.1476-5381.1983.tb09366.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  Structural requirements for, and the effects of chemicals on, the rat pulmonary inactivation of prostaglandins.

Authors:  T E Eling; H J Hawkins; M W Anderson
Journal:  Prostaglandins       Date:  1977-07

2.  Release of novel prostaglandins and thromboxanes after immunological challenge of guinea pig lung.

Authors:  W Dawson; J R Boot; A F Cockerill; D N Mallen; D J Osborne
Journal:  Nature       Date:  1976-08-19       Impact factor: 49.962

3.  Inactivation of prostaglandins in the perfused rat lung.

Authors:  C Robinson; J R Hoult
Journal:  Biochem Pharmacol       Date:  1982-03-01       Impact factor: 5.858

Review 4.  Present concepts on the mechanisms of platelet aggregation.

Authors:  B B Vargaftig; M Chignard; J Benveniste
Journal:  Biochem Pharmacol       Date:  1981-02-15       Impact factor: 5.858

5.  Release of 15-keto-13, 14-dihydro-thromboxane B2 and prostaglandin D2 during anaphylaxis as measured by radioimmunoassay.

Authors:  H Anhut; B A Peskar; W Bernauer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-12       Impact factor: 3.000

6.  Prostaglandin removal and metabolism by isolated perfused rat lung.

Authors:  M W Anderson; T E Eling
Journal:  Prostaglandins       Date:  1976-04

7.  Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations.

Authors:  R A Coleman; P P Humphrey; I Kennedy; G P Levy; P Lumley
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

8.  PGA1 and PGF2 alpha metabolism by pig pulmonary endothelium, smooth muscle, and fibroblasts.

Authors:  C Ody; Y Dieterle; I Wand; H Stalder; A F Junod
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1979-02

9.  Thromboxane B2 uptake and metabolism in isolated perfused lung. Identification and comparison with prostaglandin F2 alpha.

Authors:  C Robinson; S H Peers; K A Waddell; I A Blair; J R Hoult
Journal:  Biochim Biophys Acta       Date:  1982-08-18

10.  Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.

Authors:  M Hamberg; J Svensson; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

  10 in total
  1 in total

1.  Proceedings of the British Pharmacological Society, University of Cambridge, 6th-8th April, 1983. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.